Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Some breast cancer chemotherapy can cause permanent hair loss.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

New cancer treatments aim to reduce side effects and improve effectiveness.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.